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Abstract: The term ‘‘chronic periaortitis’’ (CP), proposed byMitchinson
in 1984, comprises 3 main entities: idiopathic retroperitoneal fibrosis
(IRF), inflammatory abdominal aortic aneurysms (IAAAs), and peri-
aneurysmal retroperitoneal fibrosis (PRF).
The presence of constitutional symptoms, high acute-phase reactants,
positive autoantibodies, and associated autoimmune diseases suggests
a systemic inflammatory process. Histopathologic findings show vas-
culitis with fibrinoid necrosis involving the aortic vasa vasorum as well
as the small and medium retroperitoneal vessels.
We reviewed the medical records of 608 patients with a diagnosis of
vasculitis involving the gastrointestinal (GI) tract at the Mayo Clinic
between January 1996 and December 2007. Only patients with biopsy-
proven or typical angiographic findings of vasculitis localized to the GI
tract were included.
Five patients were identified with evidence of CP (1 patient with
PRF, 1 with IRF, and 3 with IAAAs). Three patients were men, and
the median age at diagnosis was 49 years. The diagnosis of GI vascu-
litis and CP was made simultaneously in 4 patients. At the time of
onset, all patients had abdominal pain and constitutional manifestations;
the median erythrocyte sedimentation rate was 62.5 mm/1 h (range,
20Y86 mm/1 h). All patients had evidence of mesenteric vasculitis at
angiography. Three patients also had associated renal artery stenoses.
Abdominal computed tomography showed spleen infarcts in 2 patients,
bowel wall thickening in 1, and liver infarction in 1. Two patients un-
derwent surgical intervention for acute abdomen; there was histologic
evidence of small bowel infarcts and infarction of the spleen and liver
in 1. Oral prednisone was administered to all 5 patients (median starting
dose, 60 mg/d; range, 25Y80 mg/d). Three patients also received im-
munosuppressive agents, 1 tamoxifen, and 1 anti-tumor necrosis factor
therapy. All patients had at least 1 relapse or recurrence of vasculitis,
but at last visit, GI vasculitis and CP were in remission in all 5 patients.
This study provides evidence that GI manifestations due to mesen-
teric vasculitis may be associated with CP. Vasculitic involvement of the
renal arteries is also frequently present in these patients. Aggressive
immunosuppressive treatment should be promptly initiated to forestall
abdominal complications. These findings reinforce the hypothesis that
a vasculitic process plays an important role in the pathogenesis of CP.
(Medicine 2011;90: 28Y39)
Abbreviations: ANCA = antineutrophil cytoplasmic antibody, CP =
chronic periaortitis, CRP = C-reactive protein, CT = computerized
tomography, ENA = extractable nuclear antigens, ESR = erythrocyte
sedimentation rate, FDG-PET = 18F-fluorodeoxyglucose-positron
emission tomography, GI = gastrointestinal, HIV = human
immunodeficiency virus, IAAA = inflammatory abdominal aortic
aneurysm, IMA = inferior mesenteric artery, IRF = idiopathic
retroperitoneal fibrosis, IV = intravenous, MRA = magnetic resonance
angiography, MRI = magnetic resonance imaging, PRF =
perianeurysmal retroperitoneal fibrosis, SMA = superior mesenteric
artery.
INTRODUCTION
Chronic periaortitis (CP) is a clinical pathologic entity char-acterized by a fibroinflammatory reaction that extends
from the adventitia of the abdominal aorta and the common iliac
arteries into the retroperitoneum, and often leads to the encase-
ment of adjacent structures (ureters, inferior vena cava).31,35,43
CP may be viewed as comprising 3 main entities: idiopathic
retroperitoneal fibrosis (IRF), inflammatory abdominal aortic
aneurysms (IAAAs), and perianeurysmal retroperitoneal fibrosis
(PRF). These conditions have common clinical and histopatho-
logic findings, and thus probably represent different manifesta-
tions of the same disease.
Although CP has traditionally been considered an exuber-
ant local inflammatory response to atherosclerotic plaque anti-
gens, its clinical presentation is characterized by constitutional
symptoms and elevated inflammatory markers, which suggests a
systemic inflammatory process as the underlying pathogenesis
disease mechanism.35Y37,45
Histopathologic findings typically reveal vasculitis with fi-
brinoid necrosis involving the aortic vasa vasorum as well as the
small and medium-sized retroperitoneal vessels in most
patients.11,26,31,44,46 18F-fluorodeoxyglucose-positron emission
tomography (FDG-PET) studies in patients with CP have dem-
onstrated large-vessel vasculitis involving the abdominal aorta
and the common iliac arteries. In some patients, vasculitis also
involved the thoracic aorta and/or its main branches.40 Further-
more, an association between CP and granulomatous necrotizing
(antineutrophil cytoplasmic antibody EANCA^-associated) vas-
culitis, polyarteritis nodosa, and Henoch-Schönlein purpura has
been described in some patients.1Y7,9,10,12,14,15,17,18,22,24,28Y30,41,42,48
These findings raise the question of whether CP should be
regarded as a form of idiopathic vasculitis.
As part of a recent review of 608 consecutive patients with
vasculitis of the gastrointestinal (GI) tract seen at the Mayo
Clinic (Rochester, MN) over 12 years,39 we identified 5 patients
with evidence of CP at the time of the onset of GI symptoms.
In the current report, we describe the clinical, laboratory, radi-
ology, and pathology findings, as well as the treatment and
outcome of these 5 patients. In addition, we review the relevant




We conducted a retrospective medical record review of all
patients seen at the Mayo Clinic from January 1, 1996, through
December 31, 2007, who had a diagnosis of vasculitis involving
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the GI tract. Using the institution_s medical diagnostic linkage
system, we screened the electronic medical records for a diag-
nosis of vasculitis in combination with key indexing terms.
These terms included the following: mesenteric arteries, celiac
artery, gastric artery, hepatic artery, splenic artery, esophagus,
stomach, small intestine, jejunum, ileum, appendix, colon, rec-
tum, gallbladder, pancreas, liver, and spleen. We reviewed the
records of all identified patients with findings of vasculitis in-
volving the GI tract and IRF, IAAA, and PRF.39 The study was
approved by the Mayo Clinic Institutional Review Board.
Diagnostic Criteria
The presence of GI vasculitis was ascertained using the
following criteria:
1) recent history or presence of acquired GI manifestations;
2) histopathologic evidence of vasculitis in a GI specimen;
and/or
3) high-probability angiographic findings (smooth segmental
narrowing, dilatation, occlusion, or aneurysms affecting
1 or more GI arteries in the absence of vessel changes
suggestive of atherosclerosis or of vasculitis mimics such as
fibromuscular dysplasia) with a report by the Mayo Clinic
radiologist specifically stating that the angiographic find-
ings were consistent with vasculitis.
Retroperitoneal fibrosis and IAAAwere diagnosed by com-
puterized tomography (CT) and magnetic resonance imaging
(MRI). IAAAs were identified by the presence of aortic wall
thickening and the presence of an inflammatory soft tissue cuff
around the aneurysm.
Data Collection
The clinical records, radiologic images, pathologic speci-
mens, and autopsy data were used to abstract detailed data, in-
cluding CT and MRI, angiographic data, and results of biopsies.
Available pathologic specimens were reviewed. In addition, in-
formation on treatment regimens, response to treatment, pres-
ence and number of relapses, follow-up functional status, and
cause of death if relevant was retrieved from the clinical record
whenever available. Response to therapy was based on docu-
mentation by the treating physician. Relapses were defined as
an increase in or progression of disease activity requiring more
aggressive therapy.
Review of the Literature
We searched the PubMed database (National Library of
Medicine, Bethesda, MD) using the keywords ‘‘retroperitoneal
fibrosis,’’ ‘‘chronic periaortitis,’’ ‘‘periaortitis,’’ ‘‘Takayasu ar-
teritis,’’ ‘‘giant cell arteritis,’’ ‘‘polyarteritis nodosa,’’ ‘‘Wegener_s
granulomatosis,’’ ‘‘microscopic polyangiitis,’’ ‘‘Churg-Strauss
syndrome,’’ ‘‘Henoch-Schönlein purpura,’’ ‘‘cryoglobulinemic
vasculitis,’’ ‘‘leukocytoclastic angiitis,’’ and ‘‘glomerulonephri-
tis’’ to retrieve relevant clinical reports of the conditions of
interest.
FIGURE 1. A, Mesenteric angiogram: there are numerous areas of luminal irregularity in multiple visceral branches of the superior
mesenteric artery (arrows). Areas of smooth narrowing, as well as slight dilatation are seen. B, CT of the abdomen: retroperitoneal
fibrosis around the aorta and proximal right ureter (ureteral stent present, arrow). C, Abdominal CT angiogram: beginning in the
common hepatic and extending into the hepatic artery, the artery is dilated and irregular with areas of stenosis (arrows). D, Abdominal
CT angiogram: the SMA is irregular with a thickened wall and areas of stenosis (arrow), including stenoses involving the origins of the
jejunal and ilial branches.
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CASE REPORTS
Case 1
A 77-year-old man presented with deep vein thrombosis
of the left lower extremity, following which he was anti-
coagulated. Four months later, he noted the onset of malaise,
fever, fatigue, and anorexia. Over the next 3 months, he devel-
oped progressive abdominal pain, further appetite loss, diarrhea,
and weight loss of 13 kg in 4 months, and was hospitalized.
Upper endoscopy showed moderately severe reflux esophagitis
and hiatal hernia. Colonoscopy showed a segmental area of is-
chemic colitis. Contrast-enhanced CTof the abdomen and pelvis
revealed soft tissue thickening partially surrounding the thick-
ened infrarenal abdominal aorta and circumferentially thickened
inferior mesenteric artery (IMA) consistent with retroperito-
neal fibrosis. A visceral angiogram showed abnormalities in the
superior mesenteric artery (SMA) distribution with numerous
areas of luminal irregularity (areas of smooth narrowing, as well
as slight dilatation) in multiple visceral branches consistent
with GI vasculitis (Figure 1A). CT of the chest was unremark-
able. Left temporal artery biopsy was negative for arteritis.
Hepatitis B and C serologies, ANCA, cryoglobulins, antinuclear,
anti-DS-DNA and anti-extractable nuclear antigens (ENA) anti-
bodies were negative. Erythrocyte sedimentation rate (ESR) was
86 mm/1 h, C-reactive protein (CRP) was 15 mg/dL (normal to
8 mg/dL), and hemoglobin was 8.9 gm/dL.
Based on these findings, diagnosis of GI tract vasculitis
was made and treatment with prednisone 80 mg/d commenced.
Two weeks later, the patient was feeling significantly better
and had no fever and no abdominal cramping. Appetite, fatigue,
and overall well-being were markedly improved. ESR and CRP
were normal (8 mm/1 h and G0.3 mg/dL, respectively), and
hemoglobin was 12.8 g/dL. The prednisone dose was tapered to
10 mg by 7 months following diagnosis with continued clinical
remission. ESR and CRP were 17 mm/1 h and 1.02 mg/dL,
respectively. The prednisone dose was further tapered, albeit
very slowly because of the persistence of slightly elevated CRP
values.
Twenty-one months later, the prednisone dose was
4 mg/d. Six months later, the patient developed bilateral hy-
drocele, creatinine increased to 1.8 mg/dL, and ESR and CRP
to 35 mm/1 h and 8.4 mg/dL, respectively. The patient was still
asymptomatic; however, MRI/MR angiography (MRA) of the
chest and abdomen showed an area of aneurysmal ectasia of
the infrarenal abdominal aorta and bilateral renal artery stenoses.
There was a considerable amount of abnormal soft tissue en-
veloping the retroperitoneal vascular structures from just below
the level of the renal arteries and extending inferiorly along
the most proximal aspect of the right common iliac vessels. This
soft tissue also extended to the aortocaval space and encircled
the inferior vena cava at and below the level of the left renal
vein, resulting in extrinsic compression and narrowing of
the inferior vena cava in this region. There was compression
of the upper right ureter with moderate pyelocalyectasis,
which had developed from the prior CT. CT-guided biopsy
of the paracaval retroperitoneal soft tissue was performed,
which revealed changes consistent with retroperitoneal fibrosis
(Figure 2A).
The patient remained asymptomatic, while the prednisone
dose was kept at 4 mg/d. However, 3 months later retroperitoneal
ultrasonography showed right hydro-ureteronephrosis. A right
ureteral stent was placed (Figure 1B), prednisone was increased
to 30 mg/d, and tamoxifen 20 mg/d was started. The prednisone
dose was subsequently gradually reduced, and the stent was
periodically changed. The patient remained clinically asymp-
tomatic, while the extension of retroperitoneal soft tissue and
the size of the aneurysm remained unchanged on the several
subsequent CT scans of the abdomen and pelvis.
Three years later therapy consisted of prednisone 5 mg/d
and tamoxifen 20 mg/d. At this follow-up, there was still evi-
dence of bilateral hydroceles, but the right one had become
more tense and fuller. There was a modest increase in CRP and
ESR (3.3 mg/dL and 35 mm/1 h, respectively), and some con-
cern that fibrosis on CT might be worse. Therefore, the predni-
sone was increased to 10 mg/d and methotrexate, 15 mg/wk
substituted for the tamoxifen. At the most recent follow-up
visit 3 months later, there had been no recurrence of symptoms
attributable to GI vasculitis or retroperitoneal fibrosis, and ESR
and CRP were 5 mm/1 h and 0.4 mg/dL, respectively.
FIGURE 2. A, Photomicrographs of a core biopsy specimen
showing typical features of retroperitoneal fibrosis including dense
collagenous fibrosis (arrows, left panel) and chronic inflammation
(asterisk). Plasma cells are a prominent component of the
inflammatory infiltrate (arrows, right panel) (hematoxylin and
eosin stain). B, Photomicrographs from an abdominal aortic
aneurysm wall specimen showing a thinned medial layer
(black-staining elastic fibers, arrows, left panel) with marked
peri-adventitial fibrosis and chronic inflammation. Lymphocytes
were more prominent than plasma cells. IgG4 staining was
performed and showed no increase in IgG4 plasma cells
(left: Verhoeff-van Gieson elastic stain, right: hematoxylin and
eosin stain).
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Case 2
A 63-yearYold man was seen for a second opinion re-
garding a previous diagnosis of possible vasculitis dating back
25 years. At that time, he had developed a systemic inflam-
matory illness with fever, night sweats, fatigue, generalized
aching, and loss of appetite with nausea and abdominal pain.
He underwent an extensive evaluation including muscle biopsy,
temporal artery biopsy, and mesenteric angiogram, which were
all unrevealing. Hewas started empirically on prednisone 60 mg/
d with complete resolution of symptoms. Since that time pred-
nisone had been continued, generally at a dose of 10 mg/d, with
few interruptions. Over all these years, there had been no clear
evidence of major organ involvement.
At the time of initial evaluation at the Mayo Clinic, the
patient was taking prednisone 10 mg/d and had no clear-cut
symptoms suggestive of an underlying systemic vasculitis or
connective tissue disease. Mild renal insufficiency was noted
(creatinine, 1.6 mg/dL). Physical examination revealed only
degenerative changes of the hands.
Investigations at that point included MRA of the chest
vessels, which was negative. MRA of the abdomen showed
stenosis of the proximal celiac artery, high-grade stenosis of
the origin of the IMA, and mild to moderate stenosis of the
proximal right renal artery. There was soft tissue thickening
around the abdominal aorta, beginning at the origin of the SMA
and extending inferiorly to near the aortic bifurcation. Minor
lymphadenopathy was noted in the retroperitoneum.
CT urogram confirmed the presence of soft tissue thick-
ening in the retroperitoneum at and just inferior to the level of
the renal veins with associated lymphadenopathy. Soft tissue
thickening was also present along a nonopacified segment of the
proximal left ureter. ESR and CRPwere elevated (55 mm/1 h and
6.2 mg/dL, respectively), while immune serologies (ANCA, anti-
nuclear antibodies, cryoglobulins) were all negative. A diagno-
sis of retroperitoneal fibrosis associated with GI tract vasculitis
was made. Therapy was continued at prednisone dose 10 mg/d.
At the last follow-up 2 years later, CT urogram was un-
changed. The prednisone dose was 5 mg/d. The patient was
clinically asymptomatic, and creatinine was stable at 1.5 mg/dL;
however, the ESR remained persistently elevated (72 mm/1 h).
Case 3
A 59-year-old woman was hospitalized because of ab-
dominal pain, fever, and fatigue. Two years earlier, she had
begun to experience postprandial abdominal pain and persistent
diarrhea. The pain was described as a hot burning sensation
relieved by avoidance of food. She also had nausea with weight
loss (15 kg), mainly in the last year. An angiogram was per-
formed with evidence of right renal artery stenosis, 95% stenosis
of the origin of the celiac axis, and complete occlusion of both
the SMA and IMA. CT scans of the abdomen showed aneu-
rysmal dilatation, diffuse wall thickening, and a periaortic cuff
of inflammatory soft tissue surrounding the infrarenal abdomi-
nal aorta. A diagnosis of IAAA and GI tract vasculitis with
critical arterial occlusion was made, and aorta-mesenteric by-
pass was performed.
A few days after the intervention, the patient began again
to complain of upper abdominal pain and back pain. Ultraso-
nography showed normal appearance of the aorto-mesenteric
bypass without evidence of stenoses. CT of the abdomen and
pelvis confirmed the presence of the inflammatory aneurysm
of the infrarenal abdominal aorta extending to the level of the
bifurcation. However, it also showed diffuse wall thickening of
the GI tract from the stomach to the mid-transverse colon,
consistent with ischemic changes in the distribution of the
celiac artery and SMA. Upper endoscopy revealed multiple er-
ythematous and bloody areas suggestive of ischemia scattered
throughout the stomach and all portions of the duodenum.
Because of persisting abdominal pain aggravated by
food intake, a mesenteric arteriogram was performed, which
showed numerous smooth-tapered narrowings of multiple SMA
branches and of the right hepatic and left gastric arteries. Most
of these lesions were not present on the previous angiogram.
Treatment with prednisone 25 mg/d was initiated. ESR
was 29 mm/1 h after starting prednisone, while immunologic
tests (ANCA, antinuclear, anti-DS-DNA, and anti-ENA anti-
bodies, cryoglobulins) were all negative. The abdominal pain
gradually improved. One month after the start of prednisone
treatment, repeat CT of the abdomen and pelvis was performed,
which showed resolution of the previously noted diffuse wall
thickening of the GI tract from the stomach to the mid-transverse
colon. A new angiogram was unchanged from the previous
study, while a colonoscopy was negative. Two months later, the
patient was much improved clinically. The postprandial pain and
diarrhea had resolved, and she had gained 9 kg since the surgery.
A CT scan of the abdomen was unchanged. The prednisone dose
was tapered by 2.5 mg every 2 weeks and was discontinued after
4 months. The patient remained clinically well until 5 years later,
when she developed acute-onset abdominal pain and was found
to have an occluded bypass graft. The graft was revised; how-
ever, CT of the abdomen showed near-complete infarction of the
spleen and of a large part of the lateral segment of the left hepatic
lobe. Moderate thickening of mid-distal small bowel loops in
the lower abdomen and pelvis were also observed, consistent
with ischemia. The abdominal pain improved, but subsequently
recurred. A diagnosis of small bowel obstruction related to is-
chemic strictures was made. The patient was taken to the oper-
ating room for small bowel resection, partial resection of the
left hepatic lobe, and splenectomy. She slowly improved, and
2 months later, at the last follow-up visit, was able to tolerate an
unrestricted diet and had normal bowel function and had only
slight abdominal pain. Her only medication was prednisone
5 mg/d, which had been started 4 months previously for wide-
spread aches and pains.
Case 4
A 49-year-old woman presented with subacute onset
of dull, epigastric abdominal pain, mild nausea, and decreased
appetite. Intermittent late-afternoon fever was present. ESR was
70 mm/1 h and CRP was 8.7 mg/dL. CT of abdomen showed
a proximal abdominal aorta with diffuse wall thickening and
a periaortic cuff of inflammatory soft tissue suggestive of peri-
aortitis. A diagnosis of abdominal periaortitis was made and
treatment was initiated with prednisone 20 mg/d. Her abdominal
pain improved significantly, and 1 month later ESR and CRP
were 30 mm/1 h and 3.5 mg/dL, respectively. Two months later,
azathioprine was started as a steroid-sparing agent with a target
dose of 200 mg/d. Prednisone was maintained at 10 mg/d
because of persistently elevated ESR and CRP levels (around
50 mm/1 hour and 3.2 mg/dL, respectively).
Fourteen months later, the patient_s CRP level was
6 mg/dL and her abdominal pain was mild, but an abdominal
CT scan showed the development of an aneurysmal enlargement
of the inflamed abdominal aorta. Three months thereafter, the
abdominal pain continued to be intermittent, and the patient
still complained of poor appetite and had had a 7-kg weight loss
over the past year.
On examination, a pulsatile mass and bruit were noted in
the epigastrium. MRI/MRA showed a rapidly enlarging proxi-
mal abdominal aortic aneurysm and high-grade stenoses at the
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origins of the celiac artery and SMA with poststenotic dilata-
tion, and stenosis of the right renal artery. Diffuse aorta wall
thickening and periaortic inflammatory changes present on the
first CTwere improved. ESR was 110 mm/1 h, CRP 4.1 mg/dL,
and creatinine 1.3 mg/dL. Immunologic tests (antinuclear, anti-
DS-DNA, anti-ENA antibodies, ANCA, cryoglobulins, and
rheumatoid factor) were negative. A diagnosis of GI tract vas-
culitis was made, and the prednisone dose was increased to 40
mg/d. Twomonths later, ESR and CRP were elevated at 70 mm/1
h and 2.1 mg/dL. Despite an occasional dull ache in the epi-
gastrium, the patient had regained some weight.
Three months later, CT scan revealed an increase in size
of the aortic aneurysm and a slight worsening of the right renal
artery stenosis. Therefore, cyclophosphamide pulse therapy 1 g
intravenously (IV) administered monthly was started, while the
prednisone was maintained at 40 mg/d. Two months later, a
repeat CT angiogram of the abdomen showed worsening of
vasculitis with occlusion and diffuse wall thickening of the celiac
axis distal to the left gastric artery, occlusion at the origin of the
right renal artery, and high-grade stenosis at the origin of the left
renal artery. Left renal and spleen infarcts were also observed.
ESR and CRP were 97 mm/1 h and 12.1 mg/dL, respectively.
The crampy abdominal pain recurred, and the patient was treated
with IV pulses of methylprednisolone 120 mg/d for 8 days. At
this point, the patient underwent surgical repair of the abdominal
aortic aneurysm and reconstruction of the mesenteric and renal
arteries with 4 bypasses.
Three months later, tapering of the prednisone dose to
20 mg/d was initiated. ESR and CRP were 30 mm/1 h and
0.4 mg/dL, respectively. Six months later, while on prednisone
2.5 mg/d, the patient developed malaise, fatigue, and decreased
appetite. Her ESR was 99 mm/1 hour and CRP 4.3 mg/dL. The
prednisone dose was increased to 30 mg/d. At the last follow-up
visit 4 months later, the prednisone dose was reduced to 15 mg/d
without further recurrence of symptoms.
Case 5
A 23-year-old man developed fatigue and left upper
quadrant abdominal pain unrelated to food intake or activity
without changes in bowel habit. Physical examination showed
mild left upper tenderness with no rebound tenderness or
guarding and easily palpable abdominal aortic pulse. An abdo-
men CT scan performed 3 weeks later showed a 4.9-cm infra-
renal abdominal aortic aneurysm with diffuse wall thickening
and a surrounding periaortic inflammation, consistent with
IAAA. The internal iliac arteries and the IMA were occluded.
ESR was 20 mm/1 h; immunologic (antinuclear antibodies,
ANCA, and cryoglobulins) and microbiologic (syphilis IgG and
IgM, human immunodeficiency virus [HIV], hepatitis virus B
and C) tests were negative. Genetic consultation failed to reveal
any evidence of connective tissue dysplasia such as Ehlers-
Danlos or Marfan syndromes.
A diagnosis of GI tract vasculitis associated with IAAA
was made, and prednisone 60 mg/d was started with resolution
of the abdominal pain. The prednisone dose was gradually re-
duced. Three months later, while on prednisone dose, 10 mg/d,
the patient underwent surgical repair of the abdominal aneurysm.
Pathology of the excised aneurysm wall showed marked ad-
ventitial fibrosis and chronic inflammation with medial thinning
and focal medial loss (Figure 2B). IgG4 staining showed no
increase in IgG4 plasma cells.
Four months later, the prednisone was withdrawn, but
soon thereafter mid-epigastric waxing and waning abdominal
pain unrelated to food intake reappeared. ESR was 16 mm/1 h
and CRP 1.05 mg/dL. One month later, intermittent fever with
occasional night sweats developed. By 4 months later, CRP was
found to be increased at 3.75 mg/dL, while ESR was 11 mm/1 h.
CT angiography of the chest and abdomen showed new mural
thickening of the jejunal vessels, near-complete occlusion and
focal aneurysmal dilatation of the SMA, and stenoses and dila-
tation of multiple distal SMA branches and the hepatic artery
(Figures 1C and D). The IMA and the iliac arteries remained
chronically occluded. Prednisone was restarted at the dose of
60 mg/d in addition to methotrexate 17.5 mg/wk with complete
resolution of the clinical manifestations.
Two months later, when the prednisone dose was reduced
to 15 mg/d, the patient reported progressively increasing ab-
dominal pain. An abdominal CT scan showed segment occlusion
in the mid-SMA. The patient was then started on adalimumab
40 mg every 2 weeks by subcutaneous injection and responded
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5/23/M IAAA Periaortic V Fatigue, fever Abdominal pain 1 mo Simultaneously 20
*Before the start of therapy.
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very well. Prednisone was subsequently tapered and was com-
pletely discontinued 5 months after starting adalimumab. Ap-
proximately 10 months after starting adalimumab, methotrexate
was discontinued due to abnormal liver function tests. At his last
follow-up visit (31 months from diagnosis), the patient was on
monotherapy with adalimumab and had been off prednisone for
6 months. At that time, he was asymptomatic and had normal
ESR and CRP. CT imaging of the intraabdominal vessels showed




Of the 608 patients diagnosed at the Mayo Clinic between
1996 and 2007 with vasculitis of the GI tract, 5 patients also had
CP (1 patient with PRF, 1 with IRF and 3 with IAAAs) at the
time of the onset of GI manifestations.
Table 1 shows the clinical characteristics and laboratory
findings of the 5 patients described in detail above. Three were
men. The median age at diagnosis was 49 years. GI vasculitis
and CP were diagnosed simultaneously in 4 patients. The
time from onset of GI manifestations to diagnosis of GI vas-
culitis was 1 month for 2 patients; the median interval was
17 months.
All patients had abdominal pain. Four patients had nausea,
3 weight loss, 2 diarrhea, and 1 abdominal angina. Constitutio-
nal features (fatigue, anorexia, fever, diffuse arthralgia, and/or
myalgia) were present in all patients, while lower extremity
deep vein thrombosis, bilateral hydroceles, and night sweats
occurred in 1 patient each. Unilateral hydronephrosis occurred
in 1 patient, requiring a urethral stent. Patient 3 developed an
acute abdomen due to small bowel obstruction caused by
ischemic strictures requiring exploratory laparotomy. In this
patient, upper endoscopy showed ischemic gastritis and duode-
nitis. Patient 1 had a colonoscopy that demonstrated ischemic
colitis.
ESR before therapy was elevated in 4 of the 5 patients
with available data (median value, 62.5 mm/1 h). Immunologic
tests (antinuclear antibody, ANCA, cryoglobulins, anti-DS-
DNA, anti-ENA, and rheumatoid factor) were negative in all
5 patients.
Radiology Results
Table 2 shows the findings of conventional angiography,
MRI and/or MRA, and CT and/or CT-angiography at presenta-
tion. In all patients multiple lesions were detected affecting
multiple GI arteries. The most commonly involved blood vessel
was the IMA (4/5), followed by the SMA (3/5). Three patients
had unilateral renal artery stenosis.
At presentation, 2 patients (Patients 3 and 5) had IAAA,
while Patients 1 and 4 developed aneurysmal enlargement dur-
ing the follow-up. The latter 2 patients had evidence of inflam-
mation of the infrarenal aorta at presentation. Patient 2 already
had soft tissue thickening in the retroperitoneum and some de-
gree of retroperitoneal lymphadenopathy that remained stable
during the follow-up. CTevidence of spleen infarcts was present
in 2 patients (Patients 3 and 4), liver infarction in 1 (Patient 3),
and small and large bowel wall thickening in 1 (Patient 3).
Pathology Results
Pathology specimens were available for 3 patients. Patient 1
had a CT-guided biopsy of the retroperitoneal soft tissue mass
that confirmed the diagnosis of IRF (Figure 2A). In Patient 3,
TABLE 2. Imaging and Pathology Findings
Patient Angiography MRI/MRA CT/CT Angiography Pathology











2 V Moderate/severe stenoses
of proximal celiac artery,
IMA at the origin, and
proximal right renal artery.









3 95% stenosis of the origin
of the celiac axis,
complete occlusion of both
SMA and IMA, and right
renal artery stenosis
V Aneurysmal dilatation and
diffuse wall thickening of the
infrarenal aorta, and periaortic
cuff of soft tissue inflammation
Small bowel, liver,
and spleen infarcts
4 V High-grade stenoses at the




Infrarenal abdominal aorta with
diffuse wall thickening and
periaortic cuff of soft tissue
inflammation
V
5 V V Infrarenal abdominal aortic
aneurysm with diffuse wall
thickening and periaortic cuff
of soft tissue inflammation,





with medial thinning, and
focal medial loss; IgG4
staining showed no increase
in IgG4 plasma cells
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histologic examination of surgically removed abdominal sam-
ples showed small bowel infarcts and infarction of the spleen and
liver. Finally, in Patient 5, histologic examination of a specimen
of the abdominal aorta wall performed during aneurysm repair
showed marked adventitial fibrosis and chronic inflammation
(Figure 2B) with medial thinning and focal medial loss. IgG4
staining showed no increase in the amount of IgG4 plasma cells
infiltrating the tissue.
Treatment and Outcome
Three patients underwent surgical intervention. Patient 3
had aorto-mesenteric bypass and resections of small bowel, part
of the left liver, and spleen. Two patients (Patients 4 and 5) had
repair of the abdominal aneurysm. Patient 4 also had recon-
struction of mesenteric and renal arteries with 4 bypasses. A
right ureteral stent was placed in Patient 1.
All 5 patients received oral prednisone. The median start-
ing dose was 60 mg/d (range, 25Y80 mg/d). The details of
treatment and status of patients at last follow-up are shown in
Table 3. In 1 patient oral prednisone therapy was preceded by
pulse methylprednisolone therapy (120 mg/d for 8 d, Patient 4).
The median duration of oral prednisone therapy was 37 months
(range, 11 mo to 27 yr). Two patients were treated with pred-
nisone alone, and 3 were treated with corticosteroids and
immunosuppressive agents. Two patients (Patients 1 and 5) re-
ceived methotrexate (15 mg/wk for 3 mo and 17.5 mg/wk for
12 mo, respectively), and 1 patient (Patient 4) received oral
azathioprine (200 mg/d for 22 mo) that was subsequently
switched to monthly IV cyclophosphamide pulse therapy (1 g/mo
for 15 mo) because of a relapse. Patient 1 was also treated with
tamoxifen (20 mg/d for 36 mo), and Patient 5 with the anti-tumor
necrosis factor agent adalimumab.
Overall, all 5 patients had at least 1 relapse or recurrence.
Response to therapy was noted in all patients, even after relapses
or recurrences.
Patient 1 responded well to prednisone therapy with reso-
lution of GI and constitutional manifestations; however, he had
2 relapses when the prednisone dose was reduced to 4 mg/d
and 5 mg/d, respectively. The first relapse was characterized by
the appearance of bilateral hydroceles. Abdomen MRI/MRA
showed worsening of retroperitoneal fibrosis, aneurysmal ecta-
sia of the infrarenal aorta, and bilateral renal artery stenoses.
Therefore, the prednisone dose was increased to 30 mg/d, and
tamoxifen 20 mg/d was started.
The second relapse occurred 3 years later. Right hydrocele
was worse at inspection (more tense and fuller) and there was
some concern that fibrosis might have worsened as assessed by
CT. The prednisone dose was increased from 5 mg/d to 10 mg/d,
and methotrexate 15 mg/wk was substituted for tamoxifen. At
last follow-up 3 months later, the patient was in remission on
this same therapy.
Patient 2 had been on prednisone therapy for 27 years.
During the first 25 years, the dose was 10 mg/d. Attempts to
taper and discontinue the corticosteroid therapy failed due to
recurrences of abdominal pain. However, during the last 2 years
the patient was able to gradually reduce the prednisone dose to
5 mg/d without suffering a disease relapse. At the last follow-
up visit, CT urogram was unchanged.
Patient 3 was treated with prednisone only. Five years after
stopping therapy, she had a recurrence characterized by small
bowel ischemic obstruction as well as liver and spleen infarc-
tions. Small bowel resection, resection of part of the left liver,
and splenectomy were subsequently necessary. The patient
responded well to surgical intervention. At last follow-up visit,
2 months later, she was in remission on prednisone 5 mg/d,
which had been started 4 months previously because of gen-
eralized arthralgia and/or myalgia.
Patient 4 was successfully treated at disease onset. The first
relapse occurred 20 months after starting treatment, while she
was taking prednisone 10 mg/d. MRI/MRA showed a rapidly
enlarging abdominal aneurysm and stenoses of the celiac artery,
SMA, and right renal artery. The prednisone dose was increased
to 40 mg/d, and GI symptoms markedly improved. The second
relapse occurred 5 months later, while she was still taking
prednisone 40 mg/d because of persistent abdominal pain. The
relapse was characterized by an increase in size of the abdomi-
nal aneurysm and worsening of the right renal artery stenosis
on CT angiogram. IV cyclophosphamide pulse therapy (1 g/mo)
was started, and azathioprine discontinued, while prednisone
was maintained at the dose of 40 mg/d.
Two months later, the patient had the third relapse. She
complained of crampy abdominal pain, and a CT angiogram
revealed occlusion of the celiac artery and right renal artery,
high-grade stenosis of the left renal artery, and left renal and
spleen infarcts. IV methylprednisolone pulse therapy was
started, and she underwent an abdominal aortic aneurysm re-
pair and reconstruction of the mesenteric and renal arteries
with 4 bypasses. The GI symptoms resolved. Nine months later,
when the oral prednisone dose was reduced to 2.5 mg/d, she
developed constitutional symptoms and the ESR level increased
to 99 mm/1 h. The prednisone dose was increased to 30 mg/d. At
patient_s last follow-up visit, 4 months later, the prednisone dose
was reduced to 15 mg/d, and she was clinically asymptomatic.
Patient 5 was initially treated with prednisone only. How-
ever, 5 months after stopping therapy, prednisone had to be
restarted at the dose of 60 mg/d with methotrexate 17.5 mg/wk
because of recurrence of GI and constitutional symptoms. CT
angiogram showed new mural thickening of the jejunal vessels,
near-complete occlusion and focal aneurysmal dilatation of the
SMA, and stenoses/dilatation of multiple distal SMA branches
and the hepatic artery.
The patient responded well and symptoms resolved, and the
prednisone was again gradually tapered. However, 2 months
later, taking prednisone 15 mg/d, abdominal pain reappeared and
increased in intensity, while an abdominal angiogram showed a
new vasculitic lesion in the SMA. The patient subsequently went
into remission with anti-tumor necrosis factor therapy, and at
the last follow-up visit he was able to discontinue prednisone.
DISCUSSION
We describe here 5 patients with vasculitis of the GI tract
affecting medium-sized arteries associated with CP. GI vasculitis
and CP were diagnosed concomitantly in 4 patients, suggesting
that a common vasculitic process was involved in the patho-
genesis of both conditions. This hypothesis is further supported
by the simultaneous worsening of mesenteric vasculitis and/or
renal artery stenoses and CP observed in most of the relapses.
Still, the link between GIvasculitis and CP remains largely a
matter of debate.
CP was originally interpreted as an exuberant local in-
flammatory reaction to atherosclerotic plaques in the abdominal
aorta.35Y37 However, the presence of constitutional manifesta-
tions, elevated inflammatory markers, and, sometimes, of vari-
ous autoantibodies in CP patients reported in subsequent studies
appears to point away from a localized and toward a systemic
inflammatory process.43Y45 Consistent with this hypothesis, a
recent study demonstrated that all patients with CP had evidence
on FDG-PETof grade 2+ or 3+ vascular uptake in the abdominal
aorta and/or iliac artery, consistent with widespread large-vessel
Salvarani et al Medicine & Volume 90, Number 1, January 2011
34 www.md-journal.com * 2011 Lippincott Williams & Wilkins

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Medicine & Volume 90, Number 1, January 2011 GI Vasculitis in Chronic Periaortitis
* 2011 Lippincott Williams & Wilkins www.md-journal.com 35
Copyright © 2011 Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.




Patients Retroperitoneal Findings Vasculitides
Large vessel
Kuwana 1992 (21) 1 Bilateral ureteral obstruction with bilateral hydronephrosis
CT: periaortic retroperitoneal mass and thickening
of the aortic wall
Stenosis/dilatation of aortic
arch, left renal artery,
and splenic artery
Le Moal 2001 (23) 1 CT: thoracic-abdominal periaortitis Biopsy-negative large-vessel
giant cell arteritis
Salvarani 2005 (40) 3 Left ureteral obstruction with hydroneophrosis in 1 case
CT and FDG-PET: perivascular soft tissue mass involving
the abdominal aorta and iliac arteries in all 3 patients,
inflammatory abdominal aneurysm in 1 patient
Involvement of thoracic aorta
and/or its branches
(vascular uptake on FDG-PET)
Vaglio 2008 (47) 14 CT, MRI, FDG-PET: perivascular soft tissue mass
involving the abdominal aorta and iliac arteries
Involvement of the thoracic aorta
and its branches (9 patients
had thoracic periaortitis,




Hellstrom 1966 (14) 1 Bilateral ureteral obstruction with hydronephrosis
Pathology: fibro-inflammatory tissue showing
necrotizing vasculitis
Necrotizing vasculitis involving
small arteries of gallbladder,
liver, and testes
Carton 1969 (7) 1 Biopsies during bilateral lumbar sympathectomy:
necrotizing vasculitis of the medium-sized arteries
accompanying the sympathetic chain
Autopsy: mediastinal and retroperitoneal fibrosis
Polyarteritis nodosa (probable)
Métahni 1988 (28) 1 Bilateral ureteral obstruction with hydronephrosis
CT: retroperitoneal perianeurysmal mass
Surgical intervention for abdominal aneurysm
Polyarteritis nodosa




Hautekeete 1990 (12) 1 Bilateral ureteral obstruction with hydronephrosis
CT: soft tissue mass around the aortic
prosthesis, reaching forward toward the mesentery
Polyarteritis nodosa
Iino 1992 (17) 1 Pathology: aortic dissection with necrotizing vasculitis
in the vasa vasorum of the adventitia and media
of the thoracic aorta
Polyarteritis nodosa
van Bommel 2002 (48) 1 CT: retroperitoneal mass surrounding the
inferior cava vein and abdominal aorta
Polyarteritis nodosa
Small vessel
Baker 1978 (3) 1 Left ureteral obstruction with hydronephrosis
Pathology: fibro-inflammatory tissue with necrotizing
vasculitis involving small and medium-sized arteries
Wegener granulomatosis
Hollingworth 1980 (15) 1 Bilateral ureteral obstruction with hydronephrosis
Inferior venocavagram: blockage
at the same level as ureteral blockage
CT: no mass in the region corresponding to
inferior cava venal and ureteral obstruction
Wegener granulomatosis
Metselaar 1985 (29) 1 Left ureteral obstruction with hydronephrosis Pathology:
fibro-inflammatory tissue showing necrotizing vasculitis
Wegener granulomatosis
Leche 1985 (22) 1 Bilateral ureteral obstruction with acute renal failure
Pathology: inflammatory tissue with vasculitis
Wegener granulomatosis
Adelizzi 1986 (1) 1 Bilateral ureteral obstruction with right hydronephrosis
Pathology: inflammatory tissuewith prevalent lymphocytes,
granulomas, and numerous scattered eosinophils
Wegener granulomatosis
Sieber 1990 (41) 1 CT and aortogram: left lateral periaortic mass near the
aortic bifurcation
Exploratory laparotomy: inflammatory aortic aneurysm
extending from the renal arteries to the aortic bifurcation
Aneurysmal wall biopsy specimen: granulomatous
inflammatory process
Wegener granulomatosis
(Continued on next page)
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vasculitis involving these arteries.40 Vasculitis of the thoracic
aorta and/or its branches was documented by FDG-PET, CT
angiography, and MRA in 34% of 41 consecutive Italian CP
patients,47 while reports of aortic arch syndrome in CP appear to
confirm that CP may also affect the thoracic aorta21,23 (Table 4).
Along the same lines, autopsy studies have shown that the
adventitial inflammation and fibrosis seen in CP may not be
limited to the abdominal aorta, but may also involve the thoracic
portion.19,32
Histologic evaluation of these cases has failed to reveal
significant differences between IAAA and IRF apart from an
increase in aortic diameter in the former.35 In IAAAs, histo-
pathologic findings demonstrate that most of the thickening of
the aortic wall is due to an enlargement of the adventitia caused
by a marked inflammatory reaction.35,49 The inflammatory in-
filtrate of the aortic adventitia may have a diffuse or follicular
pattern. The nodular aggregates of inflammatory cells (mainly
lymphocytes) are usually centered around the adventitial vasa
vasorum, which show evidence of vasculitis with fibrinoid
necrosis.8,26,31,44 This inflammatory histopathologic pattern has
been found in all 3 CP subsets. These findings are in keeping
with a local immune response to an antigen probably localized in
the adventitia.
Taken together, imaging and histologic evidence suggest
that CP may represent a large-vessel vasculitis involving the ab-
dominal aorta and common iliac arteries, which in some patients
may spread to the thoracic aorta and/or its branches. This vascu-
litis may be triggered by a yet-unknown inciting antigen in the
adventitia.
In addition to large-vessel involvement, there is emerging
evidence that medium- and small-sized arteries may also be
affected in CP.8,44 Vaglio et al44 found vasculitis with fibrinoid
necrosis involving small- and medium-sized retroperitoneal
vessels in most of the IRF patients undergoing surgery.
Similarly, the cases in the current study provide evidence that
medium-sized vessels located outside the retroperitoneum
may be affected, albeit infrequently, in CP. Various case re-
ports1Y7,9,10,12,14,15,17,18,22,24,27Y30,41,42,46,48 have described the
involvement of medium- and small-sized vessels as part of
established vasculitides, particularly granulomatous, ANCA-
related necrotizing vasculitis and polyarteritis nodosa, in asso-





Patients Retroperitoneal Findings Vasculitides
ter Maaten 1993 (42) 1 Left ureteral obstruction
Pathology: necrotizing granulomatous vasculitis
Wegener granulomatosis
Middleton 1994 (30) 1 Right ureteral obstruction with hydronephrosis
CT: soft tissue retroperitoneal mass extending
bilaterally along the course of the ureters from
just below the kidney to the common iliac arteries
Wegener granulomatosis
Fink 1994 (10) 1 Right ureteral obstruction with hydronephrosis
CT: thickened ill-defined tissue around the aorta,
extending to the right iliac artery
Pathology: extensive active vasculitis
Wegener granulomatosis
Blockmans 2000 (4) 1 CT: dilatation of the distal part of
abdominal aorta, thickened aortic wall,
a patent excentric lumen surrounded by a hypodense rim
Pathology: inflammatory tissue with necrotizing
granulomatous vasculitis
Wegener granulomatosis
Izzedine 2002 (18) 1 Left ureteral obstruction with hydronephrosis
Pathology: fibro-inflammatory tissue
Wegener granulomatosis
de Roux-Serratrice 2002 (9) 1 CT: ectasia of infrarenal aorta and periaortic
inflammatory infiltration
Wegener granulomatosis
Carels 2005 (6) 1 CT: 4-cm aneurysm of the distal part of the aorta
with inflammation of the surrounding adipose tissue
Pathology: fibro-inflammatory tissue with vasculitis
and necrosis
Wegener granulomatosis
Levin 2006 (24) 1 CT, CTA, FDG-PET: periaortic soft tissue mass Wegener granulomatosis
Akman 1983 (2) 1 Bilateral ureteral obstruction with hydronephrosis
Pathology: fibrous tissue
Henoch-Schönlein purpura
Vaglio 2002 (46) 2 1st case: Left ureteral obstruction with hydronephrosis
CT: periaortic mantle of soft tissue density
surrounding the left ureter
2nd case: Right ureteral obstruction with hydronephrosis
CT and US: aneurysmal dilatation of the abdominal aorta
and perianeurysmal mantle of soft tissue density
surrounding the right ureter
ANCA-positive rapidly
progressive GMN
Martinez-Odriozola 2008 (27) 1 Bilateral ureteral obstruction with ureterohydronephrosis
CT: retroperitoneal soft-tissue mass surrounding
the aorta and extending longitudinally from renal
arteries to common iliac arteries
Pathology: fibrosis and a chronic inflammatory infiltrate
ANCA-positive rapidly
progressive GMN
Abbreviations: CTA = computed tomography angiography, US = ultrasonography, GMN = glomerulonephritis.
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These observations suggest a link between CP and vascu-
litides of small- and medium-sized vessels. Specifically, most
reported patients with vasculitis and CP presented with ureteral
obstruction and hydronephrosis (Table 4). Ureteral involve-
ment has been described as an extrarenal urogenital manifes-
tation of ANCA-related necrotizing granulomatous vasculitis
and polyarteritis nodosa.16 Vasculitis may be the cause of ure-
teral obstruction because of the direct vasculitic involvement
of the ureteral wall.13,38 Entrapment and obstruction of the
ureters by retroperitoneal fibrosis occurred in the patients with
vasculitides of small- and medium-sized vessels reported in
Table 4. These findings suggest that ureteral involvement oc-
curring in vasculitides such as ANCA-related necrotizing gran-
ulomatous vasculitis and polyarteritis nodosa may be secondary
not only to vasculitis, but also to vasculitis-associated CP.
In addition to being associated with vasculitis, CP may also
arise in the context of the so-called IgG4-related sclerosing
disease, a condition characterized by extensive T-lymphocyte-
and IgG4-bearing plasma cell infiltration of various organs
leading to fibrosis.34 On the other hand, IgG4-related retroperi-
toneal fibrosis may develop in patients without evidence of
sclerosing disease elsewhere.50 In 2008, Kasashima et al20 de-
scribed a subgroup of IAAAs showing diffuse infiltration of
IgG-4 positive plasma cells and high serum IgG4 concentra-
tions. Based on these findings, the authors suggested that this
form of IAAA might be a subset of IgG4-related sclerosing
disease. However, the same authors observed that most cases of
IAAA were non-IgG4-related, having only a few IgG4-positive
plasma cells in the aneurysm wall. In 1 patient in the current
study, a surgically resected specimen of the abdominal aorta
was available. The aneurysm wall exhibited marked adventi-
tial fibrosis and chronic inflammation; however, IgG4 staining
showed no increase in the amount of IgG4 plasma cells in-
filtrating the tissue. The role of IgG4 in the pathogenesis of
IgG4-related sclerosing disease remains unclear, but the limited
evidence available so far suggests that IgG4 infiltration might
play a role in only a minority of all AAA/CP cases.
GI involvement due to mesenteric vasculitis is common in
polyarteritis nodosa and may be associated with a poor outcome,
particularly in patients who develop an acute abdomen syn-
drome.25 In fact, peritonitis, bowel perforation, GI ischemia or
infarction, and intestinal occlusion have been found to be sig-
nificantly associated with increased mortality in a cohort of
patients with GI manifestations and systemic necrotizing vas-
culitides.33 Two patients in the current study underwent surgery
for GI manifestations. One patient had severe mesenteric vas-
culitis with complete occlusion of both mesenteric arteries and
severe obstruction of celiac artery at its origin. Despite aorto-
mesenteric bypass and corticosteroid therapy, she developed
spleen and liver infarctions as well as small bowel obstruction
due to ischemic strictures, which required small bowel resection
and partial liver resection and splenectomy. The second patient
had repair surgery of the mesenteric and renal arteries with 4
bypasses for complete occlusion of the celiac and right renal
arteries and severe stenoses of superior mesenteric and left renal
arteries. Left renal and spleen infarcts were also present.
These observations suggest that mesenteric vasculitis as-
sociated with CP is probably as severe as that seen in other
established vasculitides. Therefore, it is critical that physicians
endeavor to recognize this condition promptly, because early,
aggressive immunosuppressive treatment may prevent abdom-
inal complications.
GI manifestations were successfully treated in most of
our patients with corticosteroid therapy, which was combined
with immunosuppressive chemotherapeutic agents in 3 patients
and with anti-tumor necrosis factor agent in 1. At last visit, GI
vasculitis and CP were in remission in all 5 patients. In most
cases, relapses and recurrences were associated with tapering
of corticosteroid therapy. Patients usually responded promptly
to an increase in the dose or reintroduction of corticosteroids,
sometimes associated with immunosuppressive agents. One
relapse responded to the introduction of anti-tumor necrosis
factor therapy. Our experience supports the use of corticosteroid
treatment in CP, which usually results in the resolution of
symptoms and regression of the retroperitoneal mass.43
In conclusion, the results of the current study suggest
that GI medium-sized vasculitis occurs in the context of CP.
Awareness of this uncommon but potentially serious mani-
festation may aid the clinician in recognizing it and thus start-
ing aggressive treatment early, which may prevent severe
complications.
REFERENCES
1. Adelizzi RA, Shockley FK, Pietras JR. Wegener_s granulomatosis
with ureteric obstruction. J Rheumatol. 1986;13:448Y451.
2. Akman N, Avanoglu Y, Karabay K, Erek E, Tokgoz A, Aras E, et al.
Henoch-Schonlein purpura and retroperitoneal fibrosis. Acta
Haematol. 1983;70:400Y401.
3. Baker SB, Robinson DR. Unusual renal manifestations of Wegener_s
granulomatosis. Report of two cases. Am J Med. 1978;64:883Y889.
4. Blockmans D, Baeyens H, Van Loon R, Lauwers G, Bobbaers H.
Periaortitis and aortic dissection due to Wegener_s granulomatosis.
Clin Rheumatol. 2000;19:161Y164.
5. Bourgault I, Poli F, Roujeau JC, Shaeffer A, Rodier JM, Revuz J.
Retroperitoneal and mediastinal fibrosis complicating periarteritis
nodosa. Ann Dermatol Venereol. 1989;116:824Y825.
6. Carels T, Verbeken E, Blockmans D. p-ANCA-associated periaortitis
with histological proof of Wegener_s granulomatosis: case report.
Clin Rheumatol. 2005;24:83Y86.
7. Carton RW, Wong R. Multifocal fibrosclerosis manifested by vena
caval obstructions and associated with vasculitis. Ann Intern Med.
1969;70:81Y86.
8. Corradi D, Maestri R, Palmisano A, Bosio S, Greco P, Manenti L, et al.
Idiopathic retroperitoneal fibrosis: clinicopathologic features and
differential diagnosis. Kidney Int. 2007;72:742Y753.
9. de Roux-Serratrice C, Serratrice J, Granel B, Disdier P, Bartoli J-M,
Pache X, et al. Periaortitis heralding Wegener_s granulomatosis.
J Rheumatol. 2002;29:392Y394.
10. Fink AM, Miles KA, Wraight EP. Indium-11 labelled leukocyte
uptake in aortitis. Clin Radiol. 1994;49:863Y866.
11. Gilkeson GS, Allen NB. Retroperitoneal fibrosis. A true connective
tissue disease. Rheum Dis Clin North Am. 1996;22:23Y38.
12. Hautekeete ML, Babany G, Marcellin P, et al. Retroperitoneal
fibrosis after surgery for aortic aneurysm in a patient with periarteritis
nodosa: successful treatment with corticosteroids. J Intern Med.
1990;228:53Y56.
13. Hefty TR, Bonafede P, Stenzel P. Bilateral ureteral stricture from
polyarteritis nodosa. J Urol. 1989;141:600Y601.
14. Hellstrom HR, Perezstable EC. Retroperitoneal fibrosis with
disseminated vasculitis and intrahepatic sclerosing cholangitis.
Am J Med. 1966;40:184Y187.
15. Hollingworth P, Denman AM, Gumpel JM. Retroperitoneal fibrosis
and polyarteritis nodosa successfully treated by intensive
immunosuppression. J R Soc Med. 1980;73:61Y64.
16. Huong DL, Papo T, Piette JC, Wechsler B, Bletry O, Richard F,
Valcke JC, Godeau P. Urogenital manifestations of Wegener
granulomatosis. Medicine (Baltimore). 1995;74:152Y161.
Salvarani et al Medicine & Volume 90, Number 1, January 2011
38 www.md-journal.com * 2011 Lippincott Williams & Wilkins
Copyright © 2011 Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
17. Iino T, Eguchi K, Sakai M, Nagataki S, Ishijima M, Toriyama K.
Polyarteritis nodosa with aortic dissection: necrotizing vasculitis of
the vasa vasorum. J Rheumatol. 1992;19:1632Y1636.
18. Izzedine H, Servais A, Launay-Vacher V, Deray G. Retroperitoneal
fibrosis due to Wegener_s granulomatosis: a misdiagnosis as
tuberculosis. Am J Med. 2002;113:164Y166.
19. Jones EA, Alexander MK. Idiopathic retroperitoneal fibrosis
associated with an arteritis. Ann Rheum Dis. 1966;25:356Y360.
20. Kasashima S, Zen Y, Kawashima A, Konishi K, Sasaki H, Endo M, et al.
Inflammatory abdominal aortic aneurysm: close relationship to
IgG4-related periaortitis. Am J Surg Pathol. 2008;32:197Y204.
21. Kuwana M, Wakino S, Yoshida T, Homma M. Retroperitoneal
fibrosis associated with aortitis. Arthritis Rheum. 1992;35:1245Y1247.
22. Leche J, Feuilhade C, Ferroir JP, et al. Wegener_s disease of
urologic and neurologic onset in French. Ann Med Interne (Paris).
1985;136:353.
23. Le Moal G, Paccalin M, Roy-Peaud F, Roblot P, Becq-Giraudon B.
Horton disease manifesting as periaortitis. Rev Med Interne. 2001;22:
487Y488.
24. Levin A, Kasem S, Mader R, Naparstek Y, Friedman G, Ben-Yehuda A.
Wegener granulomatosis with back pain, periaortitis, and dural
inflammation developing while receiving monthly cyclophosphamide.
J Clin Rheumatol. 2006;12:294Y297.
25. Levine SM, Hellmann DB, Stone JH. Gastrointestinal involvement
in polyarteritis nodosa (1986Y2000): presentation and outcomes
in 24 patients. Am J Med. 2002;112:386Y391.
26. Lindell OL, Sariola HV, Lehtonen TA. The occurrence of vasculitis in
perianeurysmal fibrosis. J Urol. 1987;138:727Y729.
27. Martinez-Odriozola P, Gutierrez-Macias A, Moina Eguren L,
Arrieta Lezama J. Association of idiopathic retroperitoneal fibrosis,
rapidly progressive glomerulonephritis and antiproteinase 3
antineutrophil cytoplasmic antibodies (anti PR3-ANCA). Clin Nephrol.
2008;70:251Y254.
28. Methani K, Vital Durand D, Sibille M, Sabben F, Levrat. Abdominal
aortic aneurysm, retroperitoneal fibrosis and vasculitis. Rev Med
Interne. 1988;9:188Y190.
29. Metselaar HJ, ten Kate FJ, Weimar W. Ureter obstruction as a
complication of Wegener_s granulomatosis. Eur Urol. 1985;11:
63Y64.
30. Middleton G, Karp D, Lee E, Cush J. Wegener_s granulomatosis
presenting as lower back pain with prostatitis and ureteral obstruction.
J Rheumatol. 1994;21:566Y569.
31. Mitchinson MJ. The pathology of idiopathic retroperitoneal fibrosis.
J Clin Pathol. 1970;23:681Y689.
32. Mitchinson MJ. Aortic diseases in idiopathic retroperitoneal and
mediastinal fibrosis. J Clin Pathol. 1972;25:287Y293.
33. Pagnoux C, Mahr A, Cohen P, Guillevin L. Presentation and outcome
of gastrointestinal involvement in systemic necrotizing vasculitides:
analysis of 62 patients with polyarteritis nodosa, microscopic
polyangiitis, Wegener granulomatosis, Churg-Strauss syndrome,
or rheumatoid arthritis vasculitis. Medicine (Baltimore). 2005;84:
115Y128.
34. Palmisano A, Vaglio A. Chronic periaortitis: a fibro-inflammatory
disorder. Best Pract Res Clin Rheumatol. 2009;23:339Y353.
35. Parums DV. The spectrum of chronic periaortitis. Histopathology.
1990;16:423Y431.
36. Parums DV, Chadwick DR, Mitchinson MJ. The localisation of
immunoglobulin in chronic periaortitis. Atherosclerosis. 1986;61:
117Y123.
37. Ramshaw AL, Parums DV. The distribution of adhesion molecules in
chronic periaortitis. Histopathology. 1994;24:23Y32.
38. Ronco P, Mignon F, Lanoe Y, Roland J, Moret-Maroyer L,
Gattegno B. Ureteral stenosis in Wegener_s granulomatosis. Report
of a case. Nephron. 1982;30:201Y204.
39. Salvarani C, Calamia KT, Crowson CS, Miller DV, Broadwell AW,
Hunder GG, Matteson EL, Warrington KJ. Localized vasculitis
of the gastrointestinal tract: a case series. Rheumatology (Oxford).
2010;49:1326Y1335.
40. Salvarani C, Pipitone N, Versari A, Vaglio A, Serafini D,
Bajocchi GL, et al. Positron emission tomography (PET): evaluation
of chronic periaortitis. Arthritis Rheum. 2005;53:298Y303.
41. Sieber SC, Cuello B, Gelfman NA, Garfinkel HB. Pulmonary
capillaritis and glomerulonephritis in an antineutrophil cytoplasmic
antibody-positive patient with prior granulomatous aortitis. Arch
Pathol Lab Med. 1990;114:1223Y1226.
42. ter Maaten JC, Franssen CFM, Daenekindt AA, Hoorntje SJ.
Triple Wegener_s granulomatosis in the urogenital tract. Nephron.
1993;63:358Y359.
43. Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet.
2006;367:241Y251.
44. Vaglio A, Corradi D, Manenti L, Ferretti S, Garini G, Buzio C.
Evidence of autoimmunity in chronic periaortitis: a prospective study.
Am J Med. 2003;114:454Y462.
45. Vaglio A, Palmisano A, Corradi D, Salvarani C, Buzio C.
Retroperitoneal fibrosis: evolving concepts. Rheum Dis Clin N Am.
2007;33:803Y817.
46. Vaglio A, Manenti L, Allegri L, Ferrozzi F, Corradi D, Buzio C.
ANCA-positive periaortic vasculitis: does it fall within the spectrum
of vasculitis? J Intern Med. 2002;251:268Y271.
47. Vaglio A, Palmisano A, Buzio C, Versari A, Pipitone N, Boiardi L,
Salvarani C. Large-vessel vasculitis pattern in patients with
chronic periaortitis. Arthritis Rheum. 2008;58(Suppl):S400.
48. van Bommel E, Brouwers A, Makkus A, van Vliet A. Retroperitoneal
fibrosis and p-ANCA-associated polyarteritis nodosa: coincidental
or common etiology? Eur J Intern Med. 2002;13:392.
49. Walker DI, Bloor K, Williams G, Gillie I. Inflammatory aneurysms of
the abdominal aorta. Br J Surg. 1972;59:609Y614.
50. Zen Y, Onodera M, Inoue D, Kitao A, Matsui O, Nohara T, et al.
Retroperitoneal fibrosis: a clinicopathologic study with respect to
immunoglobulin G4. Am J Surg Pathol. 2009;33:1833Y1839.
Medicine & Volume 90, Number 1, January 2011 GI Vasculitis in Chronic Periaortitis
* 2011 Lippincott Williams & Wilkins www.md-journal.com 39
Copyright © 2011 Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
